Beam Therapeutics Inc. revenue breakdown overview

Beam Therapeutics Inc. revenue for the last year amounted to 377.71 M USD, the most of which — 377.71 M USD — came from its highest performing source at the moment, Genetic Medicines, the year earlier bringing 60.92 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Beam Therapeutics Inc. 377.71 M USD, and the year before that — 60.92 M USD.